MC1R: Three novel variants identified in a malignant melanoma association study in the Spanish population

Carcinogenesis

Volumn 28, Issue 8, 2007, Pages 1659-1664

  Fernandez, L P ^a   Milne, R L ^a   Bravo, J ^a   Lopez, J M ^a   Aviles J A ^b   Longo, M I ^b   Benitez J ^a   Lazaro P ^a   Ribas, G ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARTIC ACID; ISOLEUCINE; MELANOCORTIN 1 RECEPTOR; PHENYLALANINE; THREONINE; VALINE;

ADULT; AGE DETERMINATION; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HAIR COLOR; HAPLOTYPE; HUMAN; LENTIGO; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEVUS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEX DIFFERENCE; SKIN COLOR; SPAIN; SUN EXPOSURE; SUNBURN;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HAPLOTYPES; HUMANS; MALE; MELANOMA; MIDDLE AGED; RECEPTOR, MELANOCORTIN, TYPE 1; RISK FACTORS; SPAIN; VARIATION (GENETICS);

EID: 34548135234     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm084     Document Type: Article

References (30)

1. Saenz,S. et al. (2005) Epidemiologia del melanoma en Espana. Actas Dermosifiliogr., 96, 411-418.
2. Bataille,V. (2003) Genetic epidemiology of melanoma. Eur. J. Cancer 39, 1341-1347.
3. Rees,J.L. (2004) The genetics of sun sensitivity in humans. Am. J. Hum. Genet., 75, 739-751.
4. Sturm,R.A. et al. (2001) Human pigmentation genes: Identification structure and consequences of polymorphic variation. Gene, 277 49-62.
5. Wong,T. (2004) The relation between melanocortin 1 receptor (MC1R) variation and the generation of phenotypic diversity in the cutaneous response to ultraviolet radiation. Peptides, 26, 1965-1971.
6. Han,J. et al. (2006) Melanocortin 1 receptor variants and skin cancer risk. Int. J. Cancer, 119, 1976-1984.
7. Beaumont,K.A. et al. (2005) Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum. Mol. Genet., 14, 2145-2154.
8. Ringholm,A. et al. (2004) Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J. Invest. Dermatol., 123, 917-923.
9. Newton,R. (2005) Activation of the cAMP pathway by variant human MC1R alleles expressed in HEK and melanoma cells. Peptides, 26, 1818-1824.
10. Kanetsky,P.A. et al. (2004) Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiol. Biomarkers Prev., 13 808-819.
11. Bastiaens,M.T. et al. (2001) Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am. J. Hum. Genet., 68, 884-894.
12. Smith,R. et al. (1998) Melanocortin 1 receptor variants in an Irish population [see comment]. J. Invest. Dermatol., 111, 119-122.
13. Valverde,P. et al. (1995) Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans [see comment]. Nat. Genet., 11, 328-330.
14. Matichard,E. et al. (2004) Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J. Med. Genet., 41, e13.
15. Stratigos,A. (2006) Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk Southern European population. J. Invest. Dermatol., 126, 1842-1849.
16. Ewing,B. et al. (1998) Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res., 8, 186-194.
17. Gordon,D. et al. (1998) Consed: A graphical tool for sequence finishing. Genome Res., 8, 195-202.
18. Nickerson,D.A. et al. (1997) PolyPhred: Automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 25, 2745-2751.
19. Zhang,Y., Devries,M.E. and Skolnick,Y. (2006) Structure modeling of all identified G protein-coupled receptors in the human genome [erratum appears in PLoS Comput Biol. 2006 Mar;2(3):e29]. PLoS Computational Biology, 2, e13.
20. Emsley,P. et al. (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr., 60, 2126-2132.
21. Harding,R.M. et al. (2000) Evidence for variable selective pressures at MC1R. Am. J. Hum. Genet, 66, 1351-1361.
22. Rana,B.K. et al. (1999) High polymorphism at the human melanocortin 1 receptor locus. Genetics, 151, 1547-1557.
23. Sturm,R.A. et al. (1998) Human pigmentation genetics: The difference is only skin deep. Bioessays, 20, 712-721.
24. Fargnoli,M.C. et al. (2003) Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population. Hum. Mutat., 21, 655.
25. Palmer,J.S. et al. (2000) Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype? Am. J. Hum. Genet., 66, 176-186.
26. Valverde,P. et al. (1996) The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum. Mol. Genet., 5, 1663-1666.
27. Rotraut Mössner,N.A. et al. (2007) Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma. Arch. Dermatol. Res., 298, 371-379.
28. Jimenez-Cervantes,C. et al. (2001) Thr40 and Met122 are new partial loss-of-function natural mutations of the human melanocortin 1 receptor. FEBS Lett., 508, 44-48.
29. Yang,Y. et al. (2002) Molecular determinants of human melanocortin-4 receptor responsible for antagonist SHU9119 selective activity. J. Biol. Chem., 277, 20328-20335.
30. Fargnoli,M.C. et al. (2006) Re: MC1R ASIP and DNA repair in sporadic and familial melanoma in a Mediterranean population [see comment]. J. Natl Cancer Inst., 98, 144-145; author reply, 145-146.